Skip to main content

Table 3 Adjusted effects of select disease severity indicators on depression screening, documentation and antidepressant prescription†

From: Do competing demands of physical illness in type 2 diabetes influence depression screening, documentation and management in primary care: a cross-sectional analytic study in Aboriginal and Torres Strait Islander primary health care settings

Variables Screened with formal tool Documented Depression Prescription of antidepressant drugs
  AOR 95% CI AOR 95% CI AOR 95% CI
Renal disease          
No Reference   Reference   Reference  
Yes 0.21** 0.14 0.31 0.34** 0.15 0.75 0.69 0.37 1.29
ACR level          
<=3.4 Reference   Reference   Reference  
>3.4 0.16** 0.08 0.32 0.77 0.38 1.51 0.50 0.23 1.03
Diabetes treatment          
No medication Reference   Reference   Reference  
Oral 0.37** 0.23 0.61 0.80 0.38 1.69 0.99 0.49 2.02
Insulin/insulin+oral 0.48** 0.30 0.78 1.13 0.45 2.83 1.61 0.59 4.33
HbA1c level          
<=7.00% Reference   Reference   Reference  
>7.00%* 0.40** 0.23 0.68 0.51** 0.30 0.84 0.80 0.48 1.33
Total cholesterol          
<=4.00 mmol1-1 Reference   Reference   Reference  
>4.00 mmol 1-1 0.83 0.48 1.44 1.00 0.67 1.51 2.05 0.89 4.72
Hyperlipidaemia†          
No Reference   Reference   Reference  
Yes 1.86 0.85 4.09 1.23 0.47 3.22 1.28 0.61 2.69
  1. †adjusted for sex, age, BMI and overall delivery of scheduled services; only those disease severity indicators significant in the bi-variate analysis are included
  2. *P<0.01; **P<0.001.